About the journal

Aims and scope

MedicianX is an international, open-access, peer-reviewed journal dedicated to advancing clinical medicine and biomedical research through the rigorous publication of high-quality scholarly work. Our mission is to advance medicine and empower life by disseminating trustworthy evidence to clinicians, researchers, and health-policy leaders worldwide.

Focus

The journal welcomes contributions from every field of clinical and biomedical science that improve patient care, deepen understanding of disease mechanisms, or inform health-system practice. We prioritise studies with clear clinical relevance, methodological soundness, and ethical conduct.

Subject areas

  • Internal Medicine
  • Cardiology
  • Neurology
  • Oncology & Surgical Oncology
  • Endocrinology & Diabetes
  • Obstetrics & Gynecology
  • Pediatrics & Neonatology
  • General & Laparoscopic Surgery
  • Radiology & Imaging
  • Pathology & Laboratory Medicine
  • Public Health & Epidemiology
  • Emergency & Critical Care Medicine
  • Dentistry & Periodontology
  • ENT (Otorhinolaryngology)

Article types accepted

Original Research
Novel primary research, RCTs, cohort/case-control studies.
Review Articles
Comprehensive narrative reviews on established or emerging topics.
Systematic Reviews & Meta-analyses
PRISMA-compliant evidence syntheses.
Case Reports & Series
Instructive clinical cases with teaching value.
Clinical Trials
Registered interventional studies (CONSORT-aligned).
Editorials & Commentaries
Invited or unsolicited perspectives on important issues.
Letters to the Editor
Short scientific correspondence, ≤ 750 words.

Target readership

Practising clinicians across specialties, biomedical researchers, medical educators, postgraduate trainees, and health-policy professionals.

Publication frequency

MedicianX publishes on a continuous basis, with articles assigned to volumes and issues after acceptance. Continuous publication ensures rapid dissemination without waiting for issue compilation.

Language

All manuscripts must be submitted in English (UK or US spelling accepted).